Burning Rock Biotech Limited Share-based Payment Arrangement, Expense
Burning Rock Biotech Limited (BNR) reported Share-based Payment Arrangement, Expense of CNY 13.88 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-04-28
CNY
| Period end | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|
| 2025-12-31 | 13.88M CNY 20-F · filed 2026-04-28 | |
| 2024-12-31 | 155.62M CNY 20-F · filed 2026-04-28 | |
| 2023-12-31 | 260.72M CNY 20-F · filed 2026-04-28 | |
| 2022-12-31 | 326.78M CNY 20-F · filed 2025-04-29 | |
| 2022-06-30 | 157.29M CNY 6-K · filed 2022-11-07 | |
| 2021-12-31 | 282.43M CNY 20-F · filed 2024-04-29 | |
| 2021-06-30 | 168.17M CNY 6-K · filed 2022-11-07 | |
| 2020-12-31 | 173.22M CNY 20-F · filed 2023-04-20 | |
| 2019-12-31 | 22.79M CNY 20-F · filed 2022-04-29 | |
| 2018-12-31 | 5.09M CNY 20-F · filed 2021-03-23 |
USD
| Period end | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|
| 2025-12-31 | $1.98M 20-F · filed 2026-04-28 | |
| 2024-12-31 | $21.32M 20-F · filed 2025-04-29 | |
| 2023-12-31 | $36.72M 20-F · filed 2024-04-29 | |
| 2022-12-31 | $47.38M 20-F · filed 2023-04-20 | |
| 2022-06-30 | $23.48M 6-K · filed 2022-11-07 | |
| 2021-12-31 | $44.32M 20-F · filed 2022-04-29 | |
| 2020-12-31 | $26.55M 20-F · filed 2021-03-23 |